II. Major tranquilizers.
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D002707:Chlordiazepoxide / Q000008:administration & dosage / Q000009:adverse effects; D002746:Chlorpromazine / Q000008:administration & dosage / Q000009:adverse effects; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008094:Lithium / Q000009:adverse effects; D010546:Perphenazine / Q000008:administration & dosage / Q000009:adverse effects; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects; D011395:Promazine / Q000008:administration & dosage / Q000009:adverse effects; D011398:Promethazine / Q000008:administration & dosage / Q000009:adverse effects; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000188:drug therapy*; D012110:Reserpine / Q000008:administration & dosage / Q000009:adverse effects; D013843:Thiazines / Q000627:therapeutic use; D013881:Thioridazine / Q000008:administration & dosage / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000008:administration & dosage*; D014273:Triflupromazine / Q000008:administration & dosage / Q000009:adverse effects
D010640:Phenothiazines; D013843:Thiazines; D014149:Tranquilizing Agents; D002707:Chlordiazepoxide; D012110:Reserpine; D008094:Lithium; D011398:Promethazine; D010546:Perphenazine; D013881:Thioridazine; D011395:Promazine; D014273:Triflupromazine; D005476:Fluphenazine; D002746:Chlorpromazine